Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1990 1
1991 2
1992 1
1993 2
1994 1
1996 1
1997 5
1998 3
1999 2
2000 4
2001 3
2002 4
2003 2
2004 2
2008 3
2009 2
2010 2
2013 1
2014 1
2015 1
2016 1
2018 1
2023 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index.
Desnoyers LR, Vasiljeva O, Richardson JH, Yang A, Menendez EE, Liang TW, Wong C, Bessette PH, Kamath K, Moore SJ, Sagert JG, Hostetter DR, Han F, Gee J, Flandez J, Markham K, Nguyen M, Krimm M, Wong KR, Liu S, Daugherty PS, West JW, Lowman HB. Desnoyers LR, et al. Among authors: lowman hb. Sci Transl Med. 2013 Oct 16;5(207):207ra144. doi: 10.1126/scitranslmed.3006682. Sci Transl Med. 2013. PMID: 24132639
Therapeutic anti-VEGF antibodies.
Lien S, Lowman HB. Lien S, et al. Among authors: lowman hb. Handb Exp Pharmacol. 2008;(181):131-50. doi: 10.1007/978-3-540-73259-4_6. Handb Exp Pharmacol. 2008. PMID: 18071944 Review.
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.
Junutula JR, Raab H, Clark S, Bhakta S, Leipold DD, Weir S, Chen Y, Simpson M, Tsai SP, Dennis MS, Lu Y, Meng YG, Ng C, Yang J, Lee CC, Duenas E, Gorrell J, Katta V, Kim A, McDorman K, Flagella K, Venook R, Ross S, Spencer SD, Lee Wong W, Lowman HB, Vandlen R, Sliwkowski MX, Scheller RH, Polakis P, Mallet W. Junutula JR, et al. Among authors: lowman hb. Nat Biotechnol. 2008 Aug;26(8):925-32. doi: 10.1038/nbt.1480. Epub 2008 Jul 20. Nat Biotechnol. 2008. PMID: 18641636
Therapeutic peptides.
Lien S, Lowman HB. Lien S, et al. Among authors: lowman hb. Trends Biotechnol. 2003 Dec;21(12):556-62. doi: 10.1016/j.tibtech.2003.10.005. Trends Biotechnol. 2003. PMID: 14624865 Review. No abstract available.
Widespread monoclonal IgE antibody convergence to an immunodominant, proanaphylactic Ara h 2 epitope in peanut allergy.
Croote D, Wong JJW, Pecalvel C, Leveque E, Casanovas N, Kamphuis JBJ, Creeks P, Romero J, Sohail S, Bedinger D, Nadeau KC, Chinthrajah RS, Reber LL, Lowman HB. Croote D, et al. Among authors: lowman hb. J Allergy Clin Immunol. 2024 Jan;153(1):182-192.e7. doi: 10.1016/j.jaci.2023.08.035. Epub 2023 Sep 23. J Allergy Clin Immunol. 2024. PMID: 37748654 Free PMC article.
Preclinical efficacy of peanut-specific IgG4 antibody therapeutic IGNX001.
Croote D, Wong JJW, Creeks P, Aruva V, Landers JJ, Kwok M, Jama Z, Hamilton RG, Santos AF, O'Konek JJ, Ferrini R, Thomas GR, Lowman HB. Croote D, et al. Among authors: lowman hb. J Allergy Clin Immunol. 2024 Nov;154(5):1241-1248.e7. doi: 10.1016/j.jaci.2024.07.014. Epub 2024 Jul 26. J Allergy Clin Immunol. 2024. PMID: 39069172 Free article.
48 results